Astrana Historical Income Statement

ASTH Stock

33.48 0.01 0.03%

Historical analysis of Astrana Health income statement accounts such as Other Operating Expenses of 1.4 B, Operating Income of 88.8 M or Ebit of 111.2 M can show how well Astrana Health performed in making a profits. Evaluating Astrana Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Astrana Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Astrana Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Astrana Health is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

About Astrana Income Statement Analysis

Astrana Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Astrana Health shareholders. The income statement also shows Astrana investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Astrana Health Income Statement Chart

As of now, Astrana Health's EBIT is increasing as compared to previous years. The Astrana Health's current Total Operating Expenses is estimated to increase to about 136.9 M, while Depreciation And Amortization is projected to decrease to under 8.9 M.

Interest Expense Other Operating Expenses Ebit Total Operating Expenses Ebitda Total Revenue

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Astrana Health. It is also known as Astrana Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Total Revenue

Total revenue comprises all receipts Astrana Health generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most accounts from Astrana Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Astrana Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.As of now, Astrana Health's EBIT is increasing as compared to previous years. The Astrana Health's current Total Operating Expenses is estimated to increase to about 136.9 M, while Depreciation And Amortization is projected to decrease to under 8.9 M.

	2021	2022	2023	2024 (projected)
Cost Of Revenue	596.1M	944.7M	1.2B	1.2B
Total Revenue	773.9M	1.1B	1.4B	1.5B

Cost Of Revenue Total Revenue

Astrana Health income statement Correlations

	Interest Expense	Other Operating Expenses	Operating Income	Ebit	Total Operating Expenses	Income Before Tax	Net Income	Selling General Administrative	Ebitda	Total Other Income Expense Net	Income Tax Expense	Total Revenue	Cost Of Revenue	Depreciation And Amortization	Gross Profit	Net Income From Continuing Ops	Non Operating Income Net Other	Minority Interest	Tax Provision	Interest Income	Net Interest Income	Non Recurring	Reconciled Depreciation	Extraordinary Items
Interest Expense		0.95	0.68	0.57	0.94	0.74	0.79	0.95	0.58	0.02	0.79	0.93	0.94	0.41	0.84	0.34	-0.22	-0.12	0.52	0.93	-0.41	-0.52	-0.86	-0.86
Other Operating Expenses	0.95		0.86	0.69	0.98	0.89	0.86	0.98	0.72	-0.12	0.92	1.0	1.0	0.64	0.95	0.52	-0.18	0.04	0.65	0.82	-0.51	-0.42	-0.83	-0.74
Operating Income	0.68	0.86		0.63	0.86	0.98	0.87	0.86	0.67	-0.43	0.96	0.88	0.85	0.74	0.96	0.53	-0.32	0.15	0.6	0.49	-0.4	-0.07	-0.62	-0.44
Ebit	0.57	0.69	0.63		0.6	0.66	0.41	0.61	1.0	-0.09	0.7	0.7	0.7	0.77	0.64	0.95	0.5	0.72	0.97	0.49	-0.74	-0.24	-0.55	-0.39
Total Operating Expenses	0.94	0.98	0.86	0.6		0.9	0.9	1.0	0.62	-0.15	0.92	0.98	0.98	0.55	0.97	0.41	-0.31	-0.06	0.57	0.82	-0.41	-0.37	-0.83	-0.76
Income Before Tax	0.74	0.89	0.98	0.66	0.9		0.88	0.89	0.69	-0.26	0.94	0.91	0.89	0.75	0.97	0.56	-0.28	0.16	0.6	0.6	-0.34	-0.08	-0.66	-0.55
Net Income	0.79	0.86	0.87	0.41	0.9	0.88		0.88	0.45	-0.25	0.86	0.87	0.85	0.53	0.92	0.28	-0.49	-0.17	0.38	0.63	-0.28	-0.36	-0.73	-0.6
Selling General Administrative	0.95	0.98	0.86	0.61	1.0	0.89	0.88		0.63	-0.11	0.9	0.98	0.98	0.57	0.96	0.42	-0.3	-0.05	0.56	0.84	-0.39	-0.35	-0.82	-0.78
Ebitda	0.58	0.72	0.67	1.0	0.62	0.69	0.45	0.63		-0.11	0.72	0.72	0.73	0.81	0.67	0.95	0.47	0.71	0.96	0.49	-0.73	-0.24	-0.56	-0.39
Total Other Income Expense Net	0.02	-0.12	-0.43	-0.09	-0.15	-0.26	-0.25	-0.11	-0.11		-0.43	-0.15	-0.11	-0.23	-0.3	-0.06	0.31	-0.03	-0.24	0.33	0.41	-0.02	0.02	-0.34
Income Tax Expense	0.79	0.92	0.96	0.7	0.92	0.94	0.86	0.9	0.72	-0.43		0.93	0.92	0.66	0.97	0.55	-0.23	0.13	0.71	0.59	-0.57	-0.25	-0.73	-0.52
Total Revenue	0.93	1.0	0.88	0.7	0.98	0.91	0.87	0.98	0.72	-0.15	0.93		1.0	0.66	0.96	0.52	-0.19	0.05	0.66	0.8	-0.51	-0.39	-0.82	-0.72
Cost Of Revenue	0.94	1.0	0.85	0.7	0.98	0.89	0.85	0.98	0.73	-0.11	0.92	1.0		0.65	0.95	0.53	-0.16	0.05	0.66	0.81	-0.52	-0.43	-0.83	-0.74
Depreciation And Amortization	0.41	0.64	0.74	0.77	0.55	0.75	0.53	0.57	0.81	-0.23	0.66	0.66	0.65		0.67	0.83	0.21	0.56	0.73	0.25	-0.54	-0.11	-0.28	-0.11
Gross Profit	0.84	0.95	0.96	0.64	0.97	0.97	0.92	0.96	0.67	-0.3	0.97	0.96	0.95	0.67		0.49	-0.33	0.05	0.61	0.69	-0.42	-0.23	-0.75	-0.63
Net Income From Continuing Ops	0.34	0.52	0.53	0.95	0.41	0.56	0.28	0.42	0.95	-0.06	0.55	0.52	0.53	0.83	0.49		0.62	0.84	0.93	0.27	-0.68	-0.14	-0.3	-0.14
Non Operating Income Net Other	-0.22	-0.18	-0.32	0.5	-0.31	-0.28	-0.49	-0.3	0.47	0.31	-0.23	-0.19	-0.16	0.21	-0.33	0.62		0.79	0.5	-0.13	-0.46	-0.15	0.13	0.2
Minority Interest	-0.12	0.04	0.15	0.72	-0.06	0.16	-0.17	-0.05	0.71	-0.03	0.13	0.05	0.05	0.56	0.05	0.84	0.79		0.69	-0.1	-0.44	0.19	0.04	0.16
Tax Provision	0.52	0.65	0.6	0.97	0.57	0.6	0.38	0.56	0.96	-0.24	0.71	0.66	0.66	0.73	0.61	0.93	0.5	0.69		0.39	-0.84	-0.31	-0.48	-0.26
Interest Income	0.93	0.82	0.49	0.49	0.82	0.6	0.63	0.84	0.49	0.33	0.59	0.8	0.81	0.25	0.69	0.27	-0.13	-0.1	0.39		-0.18	-0.38	-0.79	-0.94
Net Interest Income	-0.41	-0.51	-0.4	-0.74	-0.41	-0.34	-0.28	-0.39	-0.73	0.41	-0.57	-0.51	-0.52	-0.54	-0.42	-0.68	-0.46	-0.44	-0.84	-0.18		0.62	0.45	0.08
Non Recurring	-0.52	-0.42	-0.07	-0.24	-0.37	-0.08	-0.36	-0.35	-0.24	-0.02	-0.25	-0.39	-0.43	-0.11	-0.23	-0.14	-0.15	0.19	-0.31	-0.38	0.62		0.52	0.32
Reconciled Depreciation	-0.86	-0.83	-0.62	-0.55	-0.83	-0.66	-0.73	-0.82	-0.56	0.02	-0.73	-0.82	-0.83	-0.28	-0.75	-0.3	0.13	0.04	-0.48	-0.79	0.45	0.52		0.87
Extraordinary Items	-0.86	-0.74	-0.44	-0.39	-0.76	-0.55	-0.6	-0.78	-0.39	-0.34	-0.52	-0.72	-0.74	-0.11	-0.63	-0.14	0.2	0.16	-0.26	-0.94	0.08	0.32	0.87

Click cells to compare fundamentals

Astrana Health Account Relationship Matchups

Astrana Health income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	4.7M	2.5M	5.4M	7.9M	16.1M	16.9M
Other Operating Expenses	526.2M	364.2M	675.7M	1.0B	1.3B	1.4B
Operating Income	34.4M	6.1M	98.2M	104.3M	84.6M	88.8M
Ebit	34.4M	187.9M	83.1M	94.5M	105.9M	111.2M
Total Operating Expenses	40.1M	15.6M	79.6M	95.2M	130.3M	136.9M
Income Before Tax	25.8M	8.9M	77.7M	86.6M	89.8M	94.3M
Net Income	14.1M	(23.8M)	68.9M	45.2M	60.7M	63.8M
Selling General Administrative	41.5M	15.6M	62.1M	77.7M	112.6M	118.2M
Ebitda	52.7M	206.3M	100.7M	112.1M	123.7M	129.9M
Total Other Income Expense Net	(8.6M)	2.8M	(20.4M)	(17.6M)	5.2M	5.5M
Income Tax Expense	8.2M	9.2M	31.7M	40.9M	32.0M	33.6M
Total Revenue	560.6M	370.2M	773.9M	1.1B	1.4B	1.5B
Cost Of Revenue	486.1M	348.5M	596.1M	944.7M	1.2B	1.2B
Depreciation And Amortization	18.3M	18.4M	17.5M	17.5M	17.7M	8.9M
Gross Profit	74.5M	21.7M	177.8M	199.5M	215.0M	225.7M
Net Income From Continuing Ops	17.7M	122.3M	49.3M	50.5M	57.8M	31.4M
Non Operating Income Net Other	(1.8M)	107.4M	(15.0M)	(9.7M)	(11.2M)	(10.6M)
Net Income Applicable To Common Shares	14.1M	37.9M	73.9M	49.0M	56.4M	59.2M
Minority Interest	3.6M	84.5M	24.6M	1.5M	2.9M	2.7M
Tax Provision	8.2M	56.1M	28.5M	36.1M	32.0M	22.8M
Interest Income	2.0M	2.8M	1.6M	2.0M	14.2M	14.9M
Net Interest Income	(2.7M)	(6.7M)	(3.8M)	(5.9M)	(1.9M)	(2.0M)
Reconciled Depreciation	18.8M	18.4M	17.5M	17.5M	17.7M	14.7M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:

How To Invest In Astrana

Details

Is Astrana Stock a good investment?

Details

What is Astrana Health's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.30)

Earnings Share

1.3

Revenue Per Share

36.415

Quarterly Revenue Growth

0.375

Return On Assets

0.0449

The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Astrana Historical Income Statement

About Astrana Income Statement Analysis

Astrana Health Income Statement Chart

Interest Expense

Other Operating Expenses

Total Operating Expenses

Total Revenue

Astrana Health income statement Correlations

Astrana Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Astrana Health income statement Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Revenue	+ 1.0	Other Operating Expenses
Cost Of Revenue	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Selling General Administrative	+ 1.0	Total Operating Expenses
Cost Of Revenue	+ 1.0	Total Revenue
Total Operating Expenses	+ 0.98	Other Operating Expenses

Extraordinary Items	- 0.94	Interest Income
Extraordinary Items	- 0.86	Interest Expense
Reconciled Depreciation	- 0.86	Interest Expense
Net Interest Income	- 0.84	Tax Provision
Reconciled Depreciation	- 0.83	Cost Of Revenue
Reconciled Depreciation	- 0.83	Total Operating Expenses